FDA Clearance Tracker · P130024-S009
LUTONIX 035 DRUG COATED BALLOON PTA CATHETER
Last checked: Nov 20, 2026Latest source record: Feb 7, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Feb 7, 2017
Approved
Time to decision
400 days
Received Jan 4, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P130024-S009
- Device name
- LUTONIX 035 DRUG COATED BALLOON PTA CATHETER
- Applicant
- Lutonix
- Applicant location
- New Hope, MN
- Received
- Jan 4, 2016
- Decided
- Feb 7, 2017
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P130024
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for Lutonix DCB is indicated for percutaneous transluminal angioplasty, after appropriate vessel preparation, of de novo, restenotic, or in-stent restenotic lesions up to 300 mm in length in native superficial femoral or popliteal arteries with reference vessel diameters of 4-7 mm.
Source documents
Other decisions for Lutonix
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P170003 · Decided Aug 25, 2017 · 214 days after receipt
Device type: Drug-coated peripheral transluminal angioplasty catheter (PRC) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.